Burke Steven Keith
- SEC CIK
- 0001619834
In the past year, 1 open-market sale filing worth $94.0K and no purchases.
Current role at each company
- SCYX Scynexis IncDirectoras of Sep 22, 2026
- AKBA Akebia Therapeutics, Inc.SVP, Chief Medical Officeras of Feb 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $94.0K
- 1 filing
- Net
- −$94.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Burke Steven Keith as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKBA Akebia Therapeutics, Inc.
SVP, Chief Medical Officer13 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 (view filing) | Aug 31 | 2 days | Burke Steven KeithSVP, Chief Medical Officer | SSale | −1.04K | $2.83 | −$2.95K | −0.6%171.2K after | |
| Mar 2, 2022 (view filing) | Feb 28-Mar 1 | 2 days | Burke Steven KeithSVP, Chief Medical Officer | SSale | −15.1K | $2.16 | −$32.5K | −6.5%217.7K after | 3 lots |
| Sep 1, 2022 (view filing)4:15 PM ET | Aug 31 | 1 day | Burke Steven KeithSVP, Chief Medical Officer | SSale | −1.15K | $0.3625 | −$415.79 | −0.3%418.0K after | |
| Mar 1, 2023 (view filing) | Feb 27 | 2 days | Burke Steven KeithSVP, Chief Medical Officer | SSale | −7.54K | $0.81 | −$6.11K | −1.2%608.2K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Burke Steven KeithSVP, Chief Medical Officer | SSale | −14.1K | $0.88 | −$12.4K | −2.3%594.1K after | 3 lots |
| May 18, 2023 (view filing) | May 16 | 2 days | Burke Steven KeithSVP, Chief Medical Officer | SSale | −63.6K | $1.07 | −$68.0K | −10.7%530.5K after | |
| Feb 2, 2024 (view filing) | Feb 1 | 1 day | Burke Steven KeithSVP, Chief Medical Officer | SSale | −24.3K | $1.68 | −$40.8K | −3.3%711.4K after | |
| Feb 29, 2024 (view filing) | Feb 27 | 2 days | Burke Steven KeithSVP, Chief Medical Officer | SSale | −8.37K | $1.52 | −$12.7K | −1.2%703.0K after | 10b5-1 |
| Mar 1, 2024 (view filing) | Feb 29 | 1 day | Burke Steven KeithSVP, Chief Medical Officer | SSale | −7.17K | $1.58 | −$11.3K | −1.0%695.8K after | |
| May 9, 2024 (view filing) | Aug 25, 2023 | 258 daysLate | Burke Steven KeithSVP, Chief Medical Officer | SSale | −27.0K | $1.15 | −$31.1K | −3.9%668.8K after |